Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Irritable Bowel Syndrome, April 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 94 articles: HTML format

Single Articles

1. STROZYK A, Horvath A, Kozlowska-Jalowska A, Muir J, et al
   Efficacy of a low-FODMAP diet in children with irritable bowel syndrome and functional abdominal pain-not otherwise specified: a randomized controlled trial with early termination.
   Front Pediatr. 2026;14:1809053.
   PubMed    
   Abstract available
   
   

2. WANG TT, Luo YJ, Feng W, Jiang LX, et al
   Gut microbial metabolism via hippocampal indole-AhR signaling regulates emotional symptoms.
   Cell Metab. 2026 Apr 1:S1550-4131(26)00097-5. doi: 10.1016/j.cmet.2026.
   PubMed    
   Abstract available
   
   

3. RIAZ S, Imran A, Rasheed M, Amjad A, et al
   Health benefits and value addition of bovine colostrum (BC): a comprehensive review of its nutritional and functional potential.
   Food Sci Anim Resour. 2026;46:55.
   PubMed    
   Abstract available
   
   

4. LINDSELL HB, Corsetti M, Darie AM, Magistro D, et al
   Physical and Mental Health as Biopsychosocial Correlates and Pathways Associated With Symptom Severity in Irritable Bowel Syndrome: A Cross-Sectional Structural Equation Modeling Study.
   Neurogastroenterol Motil. 2026;38:e70300.
   PubMed    
   Abstract available
   
   

5. ANDREYEV HJN, Jeffrey D, Rodgers K, Jones A, et al
   Clinical and cost effectiveness of nurse led-structured management of diarrhoea predominant irritable bowel syndrome in primary care (Lincolnshire POACHER study); a randomised control trial.
   BMC Prim Care. 2026 Apr 1. doi: 10.1186/s12875-026-03293.
   PubMed    
   
   
   

6. GUNEY-COSKUN M, Sarikaya B, Kolay E, Yigit Ziolkowski A, et al
   Frontiers in Gut Health: The Emerging Role of Berries in Microbiota Modulation and Gastrointestinal Diseases.
   Nutr Rev. 2026 Apr 1:nuaf294. doi: 10.1093.
   PubMed    
   Abstract available
   
   

7. VO TD, Luu ATP
   Exploring IBS in Vietnam: an updated review of current trends and treatment landscape.
   Front Med (Lausanne). 2026;13:1705376.
   PubMed    
   Abstract available
   
   

8. STALLMACH A, Layer P, Katzer K, Reuken PA, et al
   Lessons from irritable bowel syndrome: potential for understanding and managing post-COVID.
   Front Immunol. 2026;17:1717324.
   PubMed    
   Abstract available
   
   

9. SENJAB A, Al Ayoubi O, Tannous G, Alsharef Y, et al
   Recurrent abdominal pain as a leading symptom for branchio-oto-renal syndrome: a case report.
   J Med Case Rep. 2026 Mar 31. doi: 10.1186/s13256-026-05981.
   PubMed    
   Abstract available
   
   

10. RAMPRASAD C, Rangan V, Wu C, Makwana K, et al
    Clinical Symptoms Do Not Distinguish Sucrose Malabsorption From SIBO.
    Neurogastroenterol Motil. 2026;38:e70304.
    PubMed    
    Abstract available
    
    

11. KHASAWNEH M, Goodoory VC, Ford AC, Black CJ, et al
    Natural History of Psychological Symptoms in Individuals With Rome IV Irritable Bowel Syndrome and Association With Gastrointestinal Symptom Severity.
    Neurogastroenterol Motil. 2026;38:e70301.
    PubMed    
    Abstract available
    
    

12. GANZEVOORT IN, Berger M, de Boer M, Benninga MA, et al
    Effectiveness of hypnotherapy for paediatric abdominal pain in primary care: a randomised controlled trial.
    Br J Gen Pract. 2026 Mar 30:BJGP.2025.0459. doi: 10.3399/BJGP.2025.0459.
    PubMed    
    Abstract available
    
    

13. DIXIT K, Busi SB, Ahmed A, Kshirsagar A, et al
    Multi-meta-omics reveal distinct microbial genomic profiles and metabolic dysregulation in non-celiac gluten sensitivity.
    mSphere. 2026 Mar 30:e0085625. doi: 10.1128/msphere.00856.
    PubMed    
    Abstract available
    
    

14. MONTENEGRO-BORBOLLA E, Wakim El-Khoury J, Bertelli C, Schoepfer A, et al
    Resolution of long-term severe irritable bowel syndrome following fecal microbiota transplantation: A case report and microbiota analysis.
    Gut Microbes Rep. 2025;2:2487905.
    PubMed    
    Abstract available
    
    

15. CHEN B, Zhang Y, Du L, Jin J, et al
    Advances in the mechanism of low FODMAP diet in the treatment of irritable bowel syndrome: a review.
    Front Nutr. 2026;13:1719048.
    PubMed    
    Abstract available
    
    

16. KAYE AJ, Meyers SR, Hachuel D, Wells J, et al
    FODMAP-Targeting Digestive Enzyme Blend for Management of Gastrointestinal Symptoms: A "Real-World" Pre-Post Intervention Cohort Study.
    Gastro Hep Adv. 2026;5:100898.
    PubMed    
    Abstract available
    
    

17. WANG X, Jia Y, Wang C, Li D, et al
    Decoding serotonin in endometriosis: unveiling its role in disease pathogenesis via the gut-reproductive microbiota axis.
    Hum Reprod. 2026 Mar 29:deag047. doi: 10.1093.
    PubMed    
    Abstract available
    
    

18. STOEV S, Yanachkova V, Petkova-Gueorguieva E, Gueorguiev S, et al
    Patient-Reported Epigastric Symptom Dynamics During Trimebutine Maleate Treatment: A Post-Marketing Study.
    Medicina (Kaunas). 2026;62:499.
    PubMed    
    Abstract available
    
    

19. SVERDRUP H, Brevik A, Clausen MT, Kolby M, et al
    From Desperation to Sustainability: A Qualitative Exploration of Drivers and Barriers to Time-Restricted Eating in IBS Treatment.
    Nutrients. 2026;18:940.
    PubMed    
    Abstract available
    
    

20. JIN YW, Chen F, Cao J
    Bacillus coagulans idrc019 Attenuates Irritable Bowel Syndrome by Revealing Multimodal Protective Mechanisms.
    Microorganisms. 2026;14:701.
    PubMed    
    Abstract available
    
    

21. MOLERIU LC, Lupusoru R, Marin RC, Muntean C, et al
    Food as Friend or Foe: A Decadal Narrative Review of Dietary Patterns as Determinants of Gastrointestinal Pathophysiology and Clinical Outcomes (2015-2025).
    Int J Mol Sci. 2026;27:2837.
    PubMed    
    Abstract available
    
    

22. LIU G, Kong X, Zhao Y, Cai N, et al
    Quercetin Ameliorates Comorbid Insomnia in Diarrhea-Predominant Irritable Bowel Syndrome via the PI3K/AKT/NF-kappaB Signaling Pathway.
    Biomedicines. 2026;14:692.
    PubMed    
    Abstract available
    
    

23. DENG K, Cao J, Wang Z, He J, et al
    The Mast Cell-PAR2-TRP Axis: A Convergent Mechanism for Visceral Hypersensitivity Independent of Divergent Motility in IBS.
    Biomolecules. 2026;16:469.
    PubMed    
    Abstract available
    
    

24. LOPEZ-GONZALEZ MA, Fernandez-Ozcorta EJ, Arbinaga F, Arrayas-Grajera MJ, et al
    Symptom Severity, Body Image Dissatisfaction, and Movement Behaviors in Irritable Bowel Syndrome: Analysis of Quality of Life Determinants.
    Healthcare (Basel). 2026;14:714.
    PubMed    
    Abstract available
    
    

25. ALMARIO CV, Liu J, Higgins C, Yerneni N, et al
    Disparities in Healthcare Seeking and Physician Diagnosis of Irritable Bowel Syndrome: Results from a US Survey.
    Clin Gastroenterol Hepatol. 2026 Mar 25:S1542-3565(26)00211.
    PubMed    
    Abstract available
    
    

26. PUCCI G, Hill NG, Schneider Z, Brown TA, et al
    Relative Contributions of Gastrointestinal-Specific Hypervigilance and Anxiety in Explaining Eating Disorder Symptoms.
    J Clin Psychol. 2026 Mar 27. doi: 10.1002/jclp.70134.
    PubMed    
    Abstract available
    
    

27. LI Y, Jiang M, Pang J, Ma C, et al
    High-altitude exposure remodels the gut microbiota: health and disease.
    MedScience. 2026 Mar 27. doi: 10.1007/s11684-026-1206.
    PubMed    
    Abstract available
    
    

28. SURAN J, Pavlovic N, Bozic J, Kumric M, et al
    IBS and SIBO: Gut Microbiota, Pathophysiology, and Non-Pharmacological Interventions.
    Antibiotics (Basel). 2026;15:251.
    PubMed    
    Abstract available
    
    

29. JONES ASK, Seaton N, Harding S, Duff A, et al
    A Real-World Longitudinal Case-Study Implementing Digital Screening and Treatment for Distress in Inflammatory Bowel Disease: The COMPASS-IBD Patient Journey.
    Inflamm Bowel Dis. 2026 Jan 13:izaf259. doi: 10.1093.
    PubMed    
    Abstract available
    
    

30. AZIZ NI, Rahim A, Azam SI, Butt AS, et al
    Frequency of Functional Gastrointestinal Disorders and association with occupational stress among nurses at a tertiary care hospital in Karachi, Pakistan: an analytical cross-sectional study.
    Res Sq [Preprint]. 2026 Apr 1:rs.3.rs-9219713. doi: 10.21203/rs.3.rs-9219713.
    PubMed    
    Abstract available
    
    

31. MULLER E, Baum S, Borenstein E
    MAAMOUL: Metabolic network-based discovery of microbiome-metabolome shifts in disease.
    bioRxiv [Preprint]. 2026 Mar 30:2026.03.27.714614.
    PubMed    
    Abstract available
    
    

32. TIAN D, Liu X, Qiao H, Liu F, et al
    Map the prevalence of irritable bowel syndrome across China: a systematic review and meta-analysis.
    Front Med (Lausanne). 2026;13:1740952.
    PubMed    
    Abstract available
    
    

33. NISHIDA T, Osugi N, Amano T, Yoshihara T, et al
    Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.
    JGH Open. 2026;10:e70399.
    PubMed    
    Abstract available
    
    

34. PELLETIER K, Villarreal M, Klar R, Chey WD, et al
    Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Reintroduction in Clinical Practice: Surveying the Gaps and Opportunities.
    Gastro Hep Adv. 2026;5:100908.
    PubMed    
    Abstract available
    
    

35. EL-SAADONY MT, Saad AM, Sitohy M, Alkafaas SS, et al
    Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review.
    Front Immunol. 2026;16:1713426.
    PubMed    
    Abstract available
    
    

36. LI S, Dong W, Chen X, Tan X, et al
    Association between ultra-processed food consumption and risk of irritable bowel syndrome and functional dyspepsia: a systematic review and meta-analysis of observational studies.
    Front Med (Lausanne). 2026;13:1780040.
    PubMed    
    Abstract available
    
    

37. LI C, Liu Q, Cao J, Xu X, et al
    Patients' Knowledge, Attitudes, and Practices Regarding Non-pharmacological Treatments for Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:276-289.
    PubMed    
    Abstract available
    
    

38. EL-SALHY M, Corsetti M, Gilja OH, Gonlachanvit S, et al
    Towards a Standard Protocol for Fecal Microbiota Transplantation in Irritable Bowel Syndrome.
    J Neurogastroenterol Motil. 2026;32:185-197.
    PubMed    
    Abstract available
    
    

39. KIM JW
    From Belief to Behavior: Closing the Knowledge-Practice Gap in Irritable Bowel Syndrome Self-management.
    J Neurogastroenterol Motil. 2026;32:145-147.
    PubMed    
    
    
    

40. KULIN D, Shah A, Fairlie T, Staller K, et al
    Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS: A Systematic Review and Meta-Analysis.
    Neurogastroenterol Motil. 2026;38:e70305.
    PubMed    
    Abstract available
    
    

41. WUESTENBERGHS F, Jouet P, Piche T, Mion F, et al
    Impact of Early-Onset IBS on Schooling, Illness in Adulthood, and Career Prospects.
    Neurogastroenterol Motil. 2026;38:e70308.
    PubMed    
    Abstract available
    
    

42. MEHRAVAR S, Yeo YH, Pimentel M, Naji P, et al
    Association of pharmacotherapy with all-cause mortality among patients with irritable bowel syndrome.
    Commun Med (Lond). 2026;6:176.
    PubMed    
    Abstract available
    
    

43. HEBDEN LA, Sreh A, Hebden JM
    Functional bowel disease symptoms and a de novo raised carcinoembryonic antigen: delayed diagnosis of medullary cell thyroid carcinoma.
    BMJ Case Rep. 2026;19:e270871.
    PubMed    
    Abstract available
    
    

44. ALZAHRANI MA, Alzubide SR, Abufarhaneh E, Alqaraawi AM, et al
    Saudi consensus statements on the management of irritable bowel syndrome.
    Saudi J Gastroenterol. 2026 Apr 8. doi: 10.4103.
    PubMed    
    Abstract available
    
    

45. XU C, Shi Y, Huang W, Zhuang H, et al
    Cultural adaptation and psychometric validation of the Gastrointestinal Unhelpful Thinking Scale.
    Front Med (Lausanne). 2026;13:1807329.
    PubMed    
    Abstract available
    
    

46. WEI Y, Shi Z, Wu S, Yao X, et al
    Efficacy and safety of non-invasive transcutaneous nerve stimulation in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Ther Adv Gastroenterol. 2026;19:17562848261436121.
    PubMed    
    Abstract available
    
    

47. REISIAN M, Toben C, Ciobanu LG, Jawahar MC, et al
    A systematic review of associations between functional connectivity, mood and cognition in patients with irritable bowel syndrome.
    Brain Imaging Behav. 2026;20:71.
    PubMed    
    Abstract available
    
    

48. ISHIOH M, Nozu T, Ohgidani M, Furube E, et al
    beta-Hydroxybutyrate modulates intestinal barrier function and visceral sensitivity via a brain AMPK-orexin pathway recruiting histamine H1 receptors, basal forebrain cholinergic neurons, adenosine A2B receptors, and vagal output in rats.
    Biochem Pharmacol. 2026;250.
    PubMed    
    Abstract available
    
    

49. THOMBRE KR, Rahangdale ND, Gupta KR, Umekar MJ, et al
    Neuropeptide Y Receptor Modulators in Gut Physiology and Therapy.
    Curr Protein Pept Sci. 2026 Mar 18. doi: 10.2174/0113892037432130260204153437.
    PubMed    
    Abstract available
    
    

50. HAO M, Zhang J, Yang Z, Yuan J, et al
    Exposure to air pollution and risk of gastrointestinal diseases: A systematic review and meta-analysis of epidemiological evidence.
    Epidemiol Rev. 2026 Apr 17:mxag005. doi: 10.1093.
    PubMed    
    Abstract available
    
    

51. LI J, Qiu K, An P, Zhang Y, et al
    Influence of Tonsillectomy on Various Disease Outcomes: An Outcome-wide Association Analysis and Mendelian Randomization Analysis.
    J Otolaryngol Head Neck Surg. 2026;55:19160216261416896.
    PubMed    
    Abstract available
    
    

52. FREEMAN A, Letterman A, Boos J, Jackson S, et al
    Systemic Nickel Allergy Syndrome.
    Am J Med Open. 2026;15:100126.
    PubMed    
    Abstract available
    
    

53. BACON RL, Lawhon SD, Gray SB, Hodo CL, et al
    A review of chronic enterocolitis of rhesus macaques (Macaca mulatta) and potential as a naturally occurring model for post-infectious irritable bowel syndrome.
    Front Vet Sci. 2026;13:1759338.
    PubMed    
    Abstract available
    
    

54. HOEDT EC, Burns GL, Hedley KE, Waller S, et al
    Shared functional microbiome signatures in Parkinson's disease and constipation predominate irritable bowel syndrome despite taxonomic divergence.
    Brain Behav Immun Health. 2026;53:101218.
    PubMed    
    Abstract available
    
    

55. STORR M, Burghard A
    [Overview of the relevance of the intestinal mucus layer of the intestinal barrier - current state of knowledge and clinical perspective].
    MMW Fortschr Med. 2026;168.
    PubMed    
    Abstract available
    
    

56. WU X, Chen G, Yang L, Lv Z, et al
    Plasmid-mediated tigecycline resistance gene tet(X4) in Escherichia coli from patients with diarrhea-predominant irritable bowel syndrome.
    J Glob Antimicrob Resist. 2026 Apr 14:S2213-7165(26)00060.
    PubMed    
    Abstract available
    
    

57. GONG TM, Li Z, Mula M, Espiridion E, et al
    Associations Between Depression and Gastrointestinal Disorders in a Large Real-World Cohort.
    Cureus. 2026;18:e105261.
    PubMed    
    Abstract available
    
    

58. XIANG T, Ma W, Han X, Wang T, et al
    [Effect of electroacupuncture on intestinal mucosal barrier in IBS-D rats via NGF/TrkA pathway mediated by mast cells].
    Zhongguo Zhen Jiu. 2026;46:569-579.
    PubMed    
    Abstract available
    
    

59. KIM YS, Park SY, Kang SJ, Lee MW, et al
    Clinical guidance and practical recommendations for probiotic use in patients with irritable bowel syndrome, functional constipation, and Clostridium difficile infection considering sex-based differences: a Korean translation.
    Ewha Med J. 2026 Apr 15. doi: 10.12771/emj.2026.01256.
    PubMed    
    
    
    

60. ZHAO H, Chen F, Li B, Fu S, et al
    BDNF Exacerbates Visceral Hypersensitivity through Hippocampal TrkB-CRF Signaling in Early-Life Stress.
    Clin Lab. 2026;72.
    PubMed    
    Abstract available
    
    

61. ZHANG Z, Liu H, Su Y, Wang C, et al
    Pulmonary-Intestinal Axis: Shared Genetic Basis and Mediating Factors Identified Through Multi-Omics Analysis.
    Int J Chron Obstruct Pulmon Dis. 2026;21:561645.
    PubMed    
    Abstract available
    
    

62. MOLERIU LC, Lupusoru R, Muntean C, Piros T, et al
    Dietary Behaviors, Digestive Symptoms, and Neurovegetative Features in Disorders of Gut-Brain Interaction: A Cross-Sectional Clinical Study.
    Nutrients. 2026;18:1023.
    PubMed    
    Abstract available
    
    

63. SHANSKY YD, Esiev SS, Pokazannikova UV, Kudryavtseva YV, et al
    Integrating Metabolic and MicroRNA Profiling to the Diagnostics of Endometriosis: A Pilot Study.
    Int J Mol Sci. 2026;27:3052.
    PubMed    
    Abstract available
    
    

64. CAMILLERI M
    IBS Clinical Care Gaps and the Potential of Future Therapeutics based on Peripheral Visceral Afferent Modulation.
    Clin Gastroenterol Hepatol. 2026 Apr 11:S1542-3565(26)00239.
    PubMed    
    Abstract available
    
    

65. MCMAHON JT, Raheb Khelo R, Weinberg BD, Boulis NM, et al
    Neurogenic irritable bowel syndrome? Long-term resolution of chronic gastrointestinal stress following vagus nerve microvascular decompression: illustrative case.
    J Neurosurg Case Lessons. 2026;11:CASE2688.
    PubMed    
    Abstract available
    
    

66. SUN Z, Li L, Zhuang Y, Hu X, et al
    Association between self-reported oral symptoms and irritable bowel syndrome: A prospective cohort study based on UK Biobank.
    J Periodontol. 2026 Apr 13. doi: 10.1002/jper.70125.
    PubMed    
    Abstract available
    
    

67. LIU BD, Meluban L, Mathialagan S, Sun Y, et al
    How Are Pregnant Patients With Irritable Bowel Syndrome or Functional Dyspepsia Managed Pharmacologically? A Cross-Sectional Study Using a Global Database.
    Neurogastroenterol Motil. 2026;38:e70292.
    PubMed    
    Abstract available
    
    

68. LABUS JS, Tun G, Savoca PW, Delgadillo DR, et al
    Brain Changes Underlying Irritable Bowel Syndrome Symptom Improvement in Response to Mindfulness-Based Stress Reduction.
    Neurogastroenterol Motil. 2026;38:e70315.
    PubMed    
    Abstract available
    
    

69. KIKUCHI S, Sakata M, Imai H, Sozu T, et al
    Remote Self-help cognitive-behavioural Therapy for irritable bowel syndrome (ReSeT): protocol for a randomised controlled trial.
    BMC Gastroenterol. 2026 Apr 13. doi: 10.1186/s12876-026-04681.
    PubMed    
    
    
    

70. MALIK S
    Evaluation of senna-based laxatives' candies: A cross-sectional study on constipation management.
    Arab J Gastroenterol. 2026 Apr 11:S1687-1979(25)00176.
    PubMed    
    Abstract available
    
    

71. MATSUO A, Kanaya M
    Visceral hypersensitivity following adult chronic social defeat stress is associated with microglial remodeling in the anterior cingulate cortex.
    Psychoneuroendocrinology. 2026;188:107848.
    PubMed    
    Abstract available
    
    

72. EL-BADRY AA, Al-Quorain AA, Hosin N, van der Giezen M, et al
    Bacterial and fungal biomarkers in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD): trans-kingdom interactions, Blastocystis carriage, and enterotype-succinotype stratification.
    Gut Pathog. 2026 Apr 11. doi: 10.1186/s13099-026-00819.
    PubMed    
    
    
    

73. KLATTE K, Seiler A, Schweighoffer R, Meinlschmidt G, et al
    Development of a personalized, modular intervention to promote dignity, meaning and mindfulness in palliative patients in a swiss acute-care hospital.
    BMC Palliat Care. 2026 Apr 10. doi: 10.1186/s12904-026-02088.
    PubMed    
    
    
    

74. SHIROMANI S, Martini A, Ou X, Hall BP, et al
    Risk factors for pentosan polysulfate maculopathy.
    Can J Ophthalmol. 2026 Apr 7:S0008-4182(26)00087.
    PubMed    
    Abstract available
    
    

75. WANG Y, Tan S, Huang J, Wu Q, et al
    Current advances in restoring intestinal barrier homeostasis by natural medicines.
    Phytomedicine. 2026;155:158144.
    PubMed    
    Abstract available
    
    

76. DAHLGREN A, Gryback P, Jacobsson H, Hellstrom PM, et al
    Extended hydrogen breath test analysis for optimized diagnosis of SIBO-positive IBS patients.
    BMC Gastroenterol. 2026;26:224.
    PubMed    
    Abstract available
    
    

77. HONG L, Yang Y, Wang L, Yao Y, et al
    Metabolic difference of potentially toxic components from Psoraleae Fructus and Euodiae Fructus in Sishen formula by different compatibilities and physiologies.
    J Pharm Anal. 2026;16:101467.
    PubMed    
    Abstract available
    
    

78. NAGAMINE T
    Gut Microbiota as a Therapeutic Target for Chronic Pain Disorders.
    Innov Clin Neurosci. 2026;23.
    PubMed    
    Abstract available
    
    

79. LEE A, Rao K, Singh P, Fehlman J, et al
    A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2026 Apr 21:S1542-3565(26)00316.
    PubMed    
    Abstract available
    
    

80. ZHUO Y, Zhao L, Li D, Ding Y, et al
    Identification of LRP8 as a potential therapeutic target for irritable bowel syndrome from the proteomes of plasma and cerebrospinal fluid in a Mendelian randomization study.
    Rev Esp Enferm Dig. 2026 Apr 23. doi: 10.17235/reed.2026.11686/2025.
    PubMed    
    Abstract available
    
    

81. PENG S, Liu Q, Ni Y, Tao J, et al
    Childhood Maltreatment and Its Pathways to Irritable Bowel Syndrome in Adulthood: Insights From Sequential Mediation Analysis.
    Stress Health. 2026;42:e70178.
    PubMed    
    Abstract available
    
    

82. MA K, Hua X, Li Z, Zhang S, et al
    Network pharmacology identifies the mechanisms of action of Jianpi Yanggan Pill in treating diarrhea-predominant irritable bowel syndrome.
    Am J Transl Res. 2026;18:2507-2521.
    PubMed    
    Abstract available
    
    

83. SUKKAR GA, Kordi RE, Alahmadi RY
    Correction: A Cross-Sectional Study on Pediatric Resident Knowledge and Perceptions of Irritable Bowel Syndrome and Inflammatory Bowel Disease in Western Saudi Arabia.
    Cureus. 2026;18:c425.
    PubMed    
    Abstract available
    
    

84. NALLA S, Ruthvik BS, Rani GT, Latha IA, et al
    Ulcerative colitis initially misdiagnosed as irritable bowel syndrome: A case report.
    EJIFCC. 2026;37:372-378.
    PubMed    
    Abstract available
    
    

85. SOMMERMEYER H, Chmielowiec K, Wojtyla-Buciora P, Bernatek M, et al
    Irritable bowel syndrome clinical trials: getting the IBS Severity Scoring System responder rate right.
    Prz Gastroenterol. 2026;21:49-54.
    PubMed    
    Abstract available
    
    

86. ZHANG LY, Li XL, Jing YY, Yu LS, et al
    Early life visceral stress induces auditory brainstem sensitization and cochlear proteomic alterations in a rat model of irritable bowel syndrome.
    Neurobiol Stress. 2026;42:100812.
    PubMed    
    Abstract available
    
    

87. YUAN Y, Ou J, Fu X, Tang Y, et al
    A global-scale framework for quantifying the gut microbiome's mediating role in environmental and personal determinants of health.
    Eco Environ Health. 2026;5:100236.
    PubMed    
    Abstract available
    
    

88. MOLINO S, Piskorz MM, Lerma-Aguilera A, Mingorance FL, et al
    Tannin Phytocomplex Improves IBS-D Symptoms and Gut-Brain Markers: Prospective Pilot Study.
    Mol Nutr Food Res. 2026;70:e70451.
    PubMed    
    Abstract available
    
    

89. NAM K, Choi JH, Kim YS, Lee S, et al
    Impact of Portulaca oleracea L. extract in patients with irritable bowel syndrome.
    Intest Res. 2026 Apr 20. doi: 10.5217/ir.2025.00200.
    PubMed    
    Abstract available
    
    

90. HUTSON JM
    A 30-year Odyssey reveals the cause of 'idiopathic' chronic constipation.
    J Pediatr Surg. 2026;61:162864.
    PubMed    
    Abstract available
    
    

91. CONLEY TE, Duncan A, Modasia A, Ford AC, et al
    The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.
    Aliment Pharmacol Ther. 2026 Apr 17. doi: 10.1111/apt.70677.
    PubMed    
    Abstract available
    
    

92. ELDESOUKI MH, Gayam S
    Editorial: New Insights Into the Aetiopathogenesis of Post-Infective Irritable Bowel Syndrome and Functional Dyspepsia: A Significant Step Forward but What Next? Authors' Reply.
    Aliment Pharmacol Ther. 2026 Apr 15. doi: 10.1111/apt.70676.
    PubMed    
    
    
    

93. LIU L, Yao Y, Li S
    Comments on "Prevalence of Eating Disorders Among Adults With Irritable Bowel Syndrome: A Cross-Sectional Study".
    J Clin Gastroenterol. 2026;60:469-470.
    PubMed    
    
    
    

94. ORELL G, Barazanji N, Fernell E, Gillberg C, et al
    Traits of autism and attention-deficit/hyperactivity disorder in irritable bowel syndrome with pronounced symptoms.
    Scand J Gastroenterol. 2026 Apr 23:1-11. doi: 10.1080/00365521.2026.2661968.
    PubMed    
    Abstract available